BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 14646413)

  • 1. The sheep model of in utero gene therapy.
    Porada CD; Park P; Almeida-Porada G; Zanjani ED
    Fetal Diagn Ther; 2004; 19(1):23-30. PubMed ID: 14646413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational age of recipient determines pattern and level of transgene expression following in utero retroviral gene transfer.
    Porada CD; Park PJ; Almeida-Porada G; Liu W; Ozturk F; Glimp HA; Zanjani ED
    Mol Ther; 2005 Feb; 11(2):284-93. PubMed ID: 15668140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In utero gene therapy: transfer and long-term expression of the bacterial neo(r) gene in sheep after direct injection of retroviral vectors into preimmune fetuses.
    Porada CD; Tran N; Eglitis M; Moen RC; Troutman L; Flake AW; Zhao Y; Anderson WF; Zanjani ED
    Hum Gene Ther; 1998 Jul; 9(11):1571-85. PubMed ID: 9694156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
    Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
    Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE; Kiem HP; Andrews RG
    Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transduction of long-term-engrafting human hematopoietic stem cells by retroviral vectors.
    Porada CD; Tran ND; Almeida-Porada G; Glimp HA; Pixley JS; Zhao Y; Anderson WF; Zanjani ED
    Hum Gene Ther; 2002 May; 13(7):867-79. PubMed ID: 11975852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy progress and prospects: fetal gene therapy--first proofs of concept--some adverse effects.
    Coutelle C; Themis M; Waddington SN; Buckley SM; Gregory LG; Nivsarkar MS; David AL; Peebles D; Weisz B; Rodeck C
    Gene Ther; 2005 Nov; 12(22):1601-7. PubMed ID: 16136161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal gene therapy: opportunities and risks.
    Wagner AM; Schoeberlein A; Surbek D
    Adv Drug Deliv Rev; 2009 Aug; 61(10):813-21. PubMed ID: 19426772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ targeted prenatal gene therapy--how far are we?
    Mehta V; Abi Nader K; Waddington S; David AL
    Prenat Diagn; 2011 Jul; 31(7):720-34. PubMed ID: 21618255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral-mediated gene transfer into mammalian cells.
    Kohn DB; Kantoff PW; Eglitis MA; McLachlin JR; Moen RC; Karson E; Zwiebel JA; Nienhuis A; Karlsson S; O'Reilly R
    Blood Cells; 1987; 13(1-2):285-98. PubMed ID: 3311223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted transgene persistence after lentiviral vector-mediated fetal gene transfer in the pregnant rabbit model.
    Moreno R; Rosal M; Martinez I; Vilardell F; Gonzalez JR; Petriz J; Hernandez-Andrade E; Gratacós E; Aran JM
    J Gene Med; 2008 Sep; 10(9):951-64. PubMed ID: 18613266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of stable prenatal tolerance to beta-galactosidase by in utero gene transfer into preimmune sheep fetuses.
    Tran ND; Porada CD; Almeida-Porada G; Glimp HA; Anderson WF; Zanjani ED
    Blood; 2001 Jun; 97(11):3417-23. PubMed ID: 11369632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for human gene therapy.
    Karson EM; Polvino W; Anderson WF
    J Reprod Med; 1992 Jun; 37(6):508-14. PubMed ID: 1619603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of retroviral vector-mediated in utero gene transfer to the fetal rabbit.
    Moreno R; Rosal M; Cabero L; Gratacós E; Aran JM
    Fetal Diagn Ther; 2005; 20(6):485-93. PubMed ID: 16260880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved gene transfer and normalized enzyme levels in primitive hematopoietic progenitors from patients with mucopolysaccharidosis type I using a bioreactor.
    Pan D; Stroncek DF; Whitley CB
    J Gene Med; 2004 Dec; 6(12):1293-303. PubMed ID: 15538732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring for potential adverse effects of prenatal gene therapy: use of large animal models with relevance to human application.
    Mehta V; Abi-Nader KN; Carr D; Wallace J; Coutelle C; Waddington SN; Peebles D; David AL
    Methods Mol Biol; 2012; 891():291-328. PubMed ID: 22648778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jaagsiekte sheep retrovirus pseudotyped lentiviral vector-mediated gene transfer to fetal ovine lung.
    Davey MG; Zoltick PW; Todorow CA; Limberis MP; Ruchelli ED; Hedrick HL; Flake AW
    Gene Ther; 2012 Feb; 19(2):201-9. PubMed ID: 21654824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of gene therapy for hematopoietic stem cell using viral vectors].
    Dong WJ; Zu ZX; Liu DP; Liang CC
    Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrovirus-mediated gene transfer in lungs of living fetal sheep.
    Pitt BR; Schwarz MA; Pilewski JM; Nakayama D; Mueller GM; Robbins PD; Watkins SA; Albertine KH; Bland RD
    Gene Ther; 1995 Jul; 2(5):344-50. PubMed ID: 7671110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer into hematopoietic progenitor and stem cells: progress and problems.
    Dunbar CE; Emmons RV
    Stem Cells; 1994 Nov; 12(6):563-76. PubMed ID: 7881358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.